Cargando…

Non-Small-Cell Lung Cancer Patients with a High Predicted Risk of Irradical Resection: Can Chemoradiotherapy Offer Similar Survival?

PURPOSE: Irradical resection of non-small-cell lung cancer (NSCLC) is a detrimental prognostic factor. Recently, Rasing et al. presented an internationally validated risk score for pre-treatment prediction of irradical resection. We hypothesized that chemoradiation therapy (CRT) could serve as an al...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Joolingen, W. Hugo, Rasing, Marnix J. A., Peters, Max, van Lindert, Anne S. R., de Heer, Linda M., Aarts, Mieke J., Verhoeff, Joost J. C., van Rossum, Peter S. N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Thoracic Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810471/ https://www.ncbi.nlm.nih.gov/pubmed/34718916 http://dx.doi.org/10.1245/s10434-021-10982-3

Ejemplares similares

Prophylactic cranial irradiation in patients with small cell lung cancer in The Netherlands: A population-based study
por: Tomassen, Mathijs L., et al.
Publicado: (2021)

Quality of Life During and After Completion of Neoadjuvant Chemoradiotherapy for Esophageal and Junctional Cancer
por: Noordman, B. J., et al.
Publicado: (2019)

Effect of Extending the Original CROSS Criteria on Tumor Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients: A National Multicenter Cohort Analysis
por: Wang, Helena Hong, et al.
Publicado: (2020)

External Validation of Pretreatment Pathological Tumor Extent in Patients with Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer
por: Brinkmann, Sebastian, et al.
Publicado: (2019)

Prognostic Value of the Circumferential Resection Margin in Esophageal Cancer Patients After Neoadjuvant Chemoradiotherapy
por: Hulshoff, J. B., et al.
Publicado: (2015)

Salvage Robot-Assisted Minimally Invasive Esophagectomy (RAMIE) for T4b Esophageal Cancer After Definitive Chemoradiotherapy
por: Defize, I. L., et al.
Publicado: (2020)

Subxiphoid-subcostal thoracoscopic thymectomy for seropositive myasthenia offers equivalent remission rates and potentially faster recovery
por: Cao, Peng, et al.
Publicado: (2021)

The IRRAD Data Manager (IDM)
por: Gkotse, Blerina, et al.
Publicado: (2020)

Characteristics Predicting Short-Term and Long-Term Health-Related Quality of Life in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy and Esophagectomy
por: van der Wilk, Berend J., et al.
Publicado: (2023)

Role of fluorodeoxyglucose-positron emission tomography in predicting the pathological response and prognosis after neoadjuvant chemoradiotherapy for locally advanced non-small-cell lung cancer
por: Tanahashi, Masayuki, et al.
Publicado: (2022)

Waiting Time from Diagnosis to Treatment has no Impact on Survival in Patients with Esophageal Cancer
por: Visser, E., et al.
Publicado: (2016)

Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent
por: Parry, K., et al.
Publicado: (2015)

Transnational Access to CERN-Irrad-East-Hall
por: Moll, M.
Publicado: (2015)

Upgrade of CERN OP Webtools IRRAD Page
por: Vik, Magnus Bjerke
Publicado: (2017)

Importance of tumour volume and histology in trimodality treatment of patients with Stage IIIA non-small cell lung cancer—results from a retrospective analysis
por: Joosten, Pieter J M, et al.
Publicado: (2021)

Induction Chemoradiotherapy Followed by Surgical Resection for Clinical T3 or T4 Locally Advanced Non–Small Cell Lung Cancer
por: Shien, Kazuhiko, et al.
Publicado: (2012)

Lung transplantation in patients with a history of anatomical native lung resection
por: Iskender, Ilker, et al.
Publicado: (2022)

The Beam Profile Monitoring System for the CERN IRRAD Proton Facility
por: Ravotti, F, et al.
Publicado: (2017)

Development of a new PS IRRAD Facility website
por: Gurbanli, Konul
Publicado: (2018)

Memorandum for the H4IRRAD 2012 beam request
por: Calviani, M, et al.
Publicado: (2012)

GUI implementation for Controlling and Monitoring of the IRRAD Shuttle System
por: Abdulhalim, Aseel
Publicado: (2021)

Does thoracoscopic basal pyramid segmentectomy really offer functional advantages in comparison with thoracoscopic lower lobectomy?
por: Bongiolatti, Stefano, et al.
Publicado: (2023)

Completion pneumonectomy and chemoradiotherapy as treatment options in local recurrence of non-small-cell lung cancer
por: Kasprzyk, Mariusz, et al.
Publicado: (2015)

Thermal neutron measurements by Timepix detector in H4IRRAD at CERN
por: Biskup, B, et al.
Publicado: (2019)

Staged single-port thoracoscopic R2 sympathicotomy as a reproducible, safe and effective treatment option for debilitating severe facial blushing
por: van der Weijde, Emma, et al.
Publicado: (2022)

Loss of Skeletal Muscle Mass During Neoadjuvant Chemoradiotherapy Predicts Postoperative Mortality in Esophageal Cancer Surgery
por: Reisinger, Kostan W., et al.
Publicado: (2015)

Current and Planned Upgrades of the IRRAD and GIF++ Irradiation Facilities at CERN
por: Gkotse, Blerina, et al.
Publicado: (2018)

Measuring relative humidity in the radioactive environment of the IRRAD proton facility
por: Paerg, Marten
Publicado: (2017)

The Beam Profile Monitoring System for the CERN IRRAD Proton Facility
por: F. Ravotti
Publicado: (2016)

Python IRRAD Motor Control Application (PIMCA): How to use
por: Smith Mølholm, Alexander, et al.
Publicado: (2021)

Python IRRAD Motor Control Application (PIMCA): How it works
por: Smith Mølholm, Alexander, et al.
Publicado: (2021)

Beam Parameters Analysis Interface for the Proton Irradiation Facility (IRRAD)
por: Koppitz, Martina Maria
Publicado: (2022)

Rad51 Expression Is a Useful Predictive Factor for the Efficacy of Neoadjuvant Chemoradiotherapy in Squamous Cell Carcinoma of the Esophagus
por: Nakanoko, Tomonori, et al.
Publicado: (2013)

Commissioning and Operation of the H4IRRAD Mixed-Field Test Area
por: Kwee, R, et al.
Publicado: (2011)

Metastasectomy or Stereotactic Body Radiation Therapy With or Without Systemic Therapy for Oligometastatic Esophagogastric Cancer
por: Kroese, Tiuri E., et al.
Publicado: (2022)

Part-solid tumours: at the border of 2 worlds
por: Van Schil, Paul E, et al.
Publicado: (2021)

Textbook outcome as a composite outcome measure in non-small-cell lung cancer surgery
por: ten Berge, Martijn G, et al.
Publicado: (2020)

The overall survival impact of prophylactic cranial irradiation in limited-stage small-cell lung cancer: A systematic review and meta-analysis
por: Tomassen, Mathijs L., et al.
Publicado: (2022)

Development and Validation of a Recurrence-Free Survival Prediction Model for Locally Advanced Esophageal Squamous Cell Carcinoma with Neoadjuvant Chemoradiotherapy
por: Zhou, Yehan, et al.
Publicado: (2023)

Value of EUS in Determining Curative Resectability in Reference to CT and FDG-PET: The Optimal Sequence in Preoperative Staging of Esophageal Cancer?
por: Schreurs, L. M. A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_jg8o1nfks7tb4brqgisv5lvgdf